Animalcare Group (ANCR) Competitors

14.3% of Animalcare Group shares are held by institutional investors. 30.1% of Animalcare Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Animalcare Group has lower revenue, but higher earnings than Amryt Pharma. Amryt Pharma is trading at a lower price-to-earnings ratio than Animalcare Group, indicating that it is currently the more affordable of the two stocks.

Animalcare Group has a net margin of 5.70% compared to Amryt Pharma's net margin of 0.00%. Animalcare Group's return on equity of 4.46% beat Amryt Pharma's return on equity.

In the previous week, Amryt Pharma's average media sentiment score of 0.00 equaled Animalcare Group'saverage media sentiment score.

Alliance Pharma pays an annual dividend of GBX 2 per share and has a dividend yield of 3.1%. Animalcare Group pays an annual dividend of GBX 5.20 per share and has a dividend yield of 1.6%. Alliance Pharma pays out -32.2% of its earnings in the form of a dividend. Animalcare Group pays out 71.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Alliance Pharma is clearly the better dividend stock, given its higher yield and lower payout ratio.

Animalcare Group has a net margin of 5.70% compared to Alliance Pharma's net margin of -6.00%. Animalcare Group's return on equity of 4.46% beat Alliance Pharma's return on equity.

Animalcare Group has lower revenue, but higher earnings than Alliance Pharma. Alliance Pharma is trading at a lower price-to-earnings ratio than Animalcare Group, indicating that it is currently the more affordable of the two stocks.

In the previous week, Alliance Pharma's average media sentiment score of 0.00 equaled Animalcare Group'saverage media sentiment score.

66.3% of Alliance Pharma shares are held by institutional investors. Comparatively, 14.3% of Animalcare Group shares are held by institutional investors. 12.0% of Alliance Pharma shares are held by company insiders. Comparatively, 30.1% of Animalcare Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Alliance Pharma has a beta of 0.67, suggesting that its share price is 33% less volatile than the broader market. Comparatively, Animalcare Group has a beta of 0.663, suggesting that its share price is 34% less volatile than the broader market.

14.3% of Animalcare Group shares are held by institutional investors. Comparatively, 1.2% of Beximco Pharmaceuticals shares are held by institutional investors. 30.1% of Animalcare Group shares are held by insiders. Comparatively, 4.2% of Beximco Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Beximco Pharmaceuticals has a net margin of 13.13% compared to Animalcare Group's net margin of 5.70%. Beximco Pharmaceuticals' return on equity of 12.72% beat Animalcare Group's return on equity.

In the previous week, Animalcare Group's average media sentiment score of 0.00 equaled Beximco Pharmaceuticals'average media sentiment score.

Animalcare Group pays an annual dividend of GBX 5.20 per share and has a dividend yield of 1.6%. Beximco Pharmaceuticals pays an annual dividend of GBX 396.85 per share and has a dividend yield of 933.8%. Animalcare Group pays out 71.2% of its earnings in the form of a dividend. Beximco Pharmaceuticals pays out 27.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Beximco Pharmaceuticals is clearly the better dividend stock, given its higher yield and lower payout ratio.

Animalcare Group has a beta of 0.663, meaning that its share price is 34% less volatile than the broader market. Comparatively, Beximco Pharmaceuticals has a beta of 0.61, meaning that its share price is 39% less volatile than the broader market.

Beximco Pharmaceuticals has higher revenue and earnings than Animalcare Group. Beximco Pharmaceuticals is trading at a lower price-to-earnings ratio than Animalcare Group, indicating that it is currently the more affordable of the two stocks.

Venture Life Group has a net margin of 17.42% compared to Animalcare Group's net margin of 5.70%. Venture Life Group's return on equity of 7.82% beat Animalcare Group's return on equity.

In the previous week, Venture Life Group had 7 more articles in the media than Animalcare Group. MarketBeat recorded 7 mentions for Venture Life Group and 0 mentions for Animalcare Group. Venture Life Group's average media sentiment score of 1.33 beat Animalcare Group's score of 0.00 indicating that Venture Life Group is being referred to more favorably in the media.

Animalcare Group has higher revenue and earnings than Venture Life Group. Venture Life Group is trading at a lower price-to-earnings ratio than Animalcare Group, indicating that it is currently the more affordable of the two stocks.

22.9% of Venture Life Group shares are owned by institutional investors. Comparatively, 14.3% of Animalcare Group shares are owned by institutional investors. 7.3% of Venture Life Group shares are owned by company insiders. Comparatively, 30.1% of Animalcare Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Venture Life Group has a beta of 0.239, meaning that its stock price is 76% less volatile than the broader market. Comparatively, Animalcare Group has a beta of 0.663, meaning that its stock price is 34% less volatile than the broader market.